✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

CRISPR Therapeutics AG

Common Name
CRISPR Therapeutics
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Employees
393
Ticker
CRSP
Exchange
NASDAQ/NMS
Description
Crispr Therapeutics AG is a pioneering biotechnology company specializing in gene editing. Its primary function is to advance the development and application of CRISPR/Cas9 technology, which allows fo...

Disclosures of CRISPR Therapeutics

Explore CRISPR Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from CRISPR Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of CRISPR Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across CRISPR Therapeutics's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Annual Report
2024
Financial & Extra-Financial Disclosure
2024
Annual Report
2023
Financial & Extra-Financial Disclosure
2023
Annual Report
2022
Annual Report
2021
Annual Report
2020
Annual Report
2019
Annual Report
2018
Annual Report
2017
Annual Report
2016
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?